148 related articles for article (PubMed ID: 18048647)
1. ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia.
Chen L; Huynh L; Apgar J; Tang L; Rassenti L; Weiss A; Kipps TJ
Blood; 2008 Mar; 111(5):2685-92. PubMed ID: 18048647
[TBL] [Abstract][Full Text] [Related]
2. Methodological comparison of two anti-ZAP-70 antibodies.
Degheidy HA; Venzon DJ; Farooqui MZ; Abbasi F; Arthur DC; Wilson WH; Wiestner A; Stetler-Stevenson MA; Marti GE
Cytometry B Clin Cytom; 2011 Sep; 80(5):300-8. PubMed ID: 21472849
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the B cell receptor structure.
Tolar P; Pierce SK
Science; 2022 Aug; 377(6608):819-820. PubMed ID: 35981020
[TBL] [Abstract][Full Text] [Related]
4. B-cell receptor signaling in chronic lymphocytic leukemia.
Stevenson FK; Krysov S; Davies AJ; Steele AJ; Packham G
Blood; 2011 Oct; 118(16):4313-20. PubMed ID: 21816833
[TBL] [Abstract][Full Text] [Related]
5. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
Davis RE; Ngo VN; Lenz G; Tolar P; Young RM; Romesser PB; Kohlhammer H; Lamy L; Zhao H; Yang Y; Xu W; Shaffer AL; Wright G; Xiao W; Powell J; Jiang JK; Thomas CJ; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Johnson NA; Rimsza LM; Campo E; Jaffe ES; Wilson WH; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pierce SK; Staudt LM
Nature; 2010 Jan; 463(7277):88-92. PubMed ID: 20054396
[TBL] [Abstract][Full Text] [Related]
6. Identification and Functional Investigation of Hub Genes Associated with Follicular Lymphoma.
Zhu Y; Jin X; Liu J; Yang W
Biochem Genet; 2024 May; ():. PubMed ID: 38802691
[TBL] [Abstract][Full Text] [Related]
7. ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV-unmutated chronic lymphocytic leukemia.
Chen J; Sathiaseelan V; Reddy Chilamakuri CS; Roamio Franklin VN; Jakwerth CA; D'Santos C; Ringshausen I
Blood Adv; 2024 Mar; 8(5):1167-1178. PubMed ID: 38113463
[TBL] [Abstract][Full Text] [Related]
8. A Story of Kinases and Adaptors: The Role of Lck, ZAP-70 and LAT in Switch Panel Governing T-Cell Development and Activation.
Fernández-Aguilar LM; Vico-Barranco I; Arbulo-Echevarria MM; Aguado E
Biology (Basel); 2023 Aug; 12(9):. PubMed ID: 37759563
[TBL] [Abstract][Full Text] [Related]
9. A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome.
Wagner A; Rouleau M; Villeneuve L; Le T; Peltier C; Allain ÉP; Beaudoin C; Tremblay S; Courtier F; Nguyen Van Long F; Laverdière I; Lévesque É; Banerji V; Vanura K; Guillemette C
Cells; 2023 May; 12(9):. PubMed ID: 37174695
[TBL] [Abstract][Full Text] [Related]
10. Structural Complementarity of Bruton's Tyrosine Kinase and Its Inhibitors for Implication in B-Cell Malignancies and Autoimmune Diseases.
Najmi A; Thangavel N; Mohanan AT; Qadri M; Albratty M; Ashraf SE; Saleh SF; Nayeem M; Mohan S
Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986499
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL.
Collins MA; Jung IY; Zhao Z; Apodaca K; Kong W; Lundh S; Fraietta JA; Kater AP; Sun C; Wiestner A; Melenhorst JJ
Cancer Res Commun; 2022 Sep; 2(9):1089-1103. PubMed ID: 36922932
[TBL] [Abstract][Full Text] [Related]
12. A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression.
Abrisqueta P; Medina D; Villacampa G; Lu J; Alcoceba M; Carabia J; Boix J; Tazón-Vega B; Iacoboni G; Bobillo S; Marín-Niebla A; González M; Zenz T; Crespo M; Bosch F
Blood Adv; 2022 Nov; 6(21):5763-5773. PubMed ID: 35973197
[TBL] [Abstract][Full Text] [Related]
13. The TKI Era in Chronic Leukemias.
De Novellis D; Cacace F; Caprioli V; Wierda WG; Mahadeo KM; Tambaro FP
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959482
[TBL] [Abstract][Full Text] [Related]
14. Naturally Occurring Genetic Alterations in Proximal TCR Signaling and Implications for Cancer Immunotherapy.
Kent A; Longino NV; Christians A; Davila E
Front Immunol; 2021; 12():658611. PubMed ID: 34012443
[TBL] [Abstract][Full Text] [Related]
15. TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.
Kennedy E; Coulter E; Halliwell E; Profitos-Peleja N; Walsby E; Clark B; Phillips EH; Burley TA; Mitchell S; Devereux S; Fegan CD; Jones CI; Johnston R; Chevassut T; Schulz R; Seiffert M; Agathanggelou A; Oldreive C; Davies N; Stankovic T; Liloglou T; Pepper C; Pepper AGS
Blood; 2021 Jun; 137(22):3064-3078. PubMed ID: 33512408
[TBL] [Abstract][Full Text] [Related]
16. ZAP-70 Shapes the Immune Microenvironment in B Cell Malignancies.
Chen J; Moore A; Ringshausen I
Front Oncol; 2020; 10():595832. PubMed ID: 33194762
[TBL] [Abstract][Full Text] [Related]
17. Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review.
Grywalska E; Zaborek M; Łyczba J; Hrynkiewicz R; Bębnowska D; Becht R; Sosnowska-Pasiarska B; Smok-Kalwat J; Pasiarski M; Góźdź S; Roliński J; Niedźwiedzka-Rystwej P
Cells; 2020 Nov; 9(11):. PubMed ID: 33147729
[TBL] [Abstract][Full Text] [Related]
18. Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing?
Haselager MV; Kater AP; Eldering E
Front Oncol; 2020; 10():592205. PubMed ID: 33134182
[TBL] [Abstract][Full Text] [Related]
19. Systematic Analysis of Spleen Tyrosine Kinase Expression and its Clinical Outcomes in Various Cancers.
Alwithenani AI; Althubiti MA
Saudi J Med Med Sci; 2020; 8(2):95-104. PubMed ID: 32587490
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells.
Lamb DJ; Rust A; Rudisch A; Glüxam T; Harrer N; Machat H; Christ I; Colbatzky F; Wernitznig A; Osswald A; Sommergruber W
Oncotarget; 2020 Apr; 11(14):1257-1272. PubMed ID: 32292575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
